These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 23441306

  • 1. Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety.
    Kariyawasam HK, Rotiroti G, Robinson DS.
    Rhinology; 2013 Mar; 51(1):9-17. PubMed ID: 23441306
    [Abstract] [Full Text] [Related]

  • 2. Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?
    Caminati M, Dama A, Schiappoli M, Senna G.
    Expert Rev Clin Immunol; 2013 Oct; 9(10):937-47. PubMed ID: 24099148
    [Abstract] [Full Text] [Related]

  • 3. Sublingual immunotherapy for allergic rhinitis: an update.
    Burastero SE.
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):197-201. PubMed ID: 16728900
    [Abstract] [Full Text] [Related]

  • 4. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW, Passalacqua G.
    Allergy; 2006 Jun; 61 Suppl 81():20-3. PubMed ID: 16792602
    [Abstract] [Full Text] [Related]

  • 5. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN, Cobanoglu N.
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [Abstract] [Full Text] [Related]

  • 6. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
    Wise SK, Schlosser RJ.
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
    [Abstract] [Full Text] [Related]

  • 7. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE.
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of sublingual immunotherapy.
    Scadding G, Durham S.
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [Abstract] [Full Text] [Related]

  • 9. Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients.
    Masuyama K, Goto M, Takeno S, Ohta N, Okano M, Kamijo A, Suzuki M, Terada T, Sakurai D, Horiguchi S, Honda K, Matsune S, Yamada T, Sakashita M, Yuta A, Fuchiwaki T, Miyanohara I, Nakayama T, Okamoto Y, Fujieda S.
    Auris Nasus Larynx; 2016 Feb; 43(1):1-9. PubMed ID: 26615715
    [Abstract] [Full Text] [Related]

  • 10. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L, Wallace D.
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [Abstract] [Full Text] [Related]

  • 11. Sublingual immunotherapy for allergic rhinitis: where are we now?
    Incorvaia C, Mauro M, Ridolo E.
    Immunotherapy; 2015 Aug; 7(10):1105-10. PubMed ID: 26507464
    [Abstract] [Full Text] [Related]

  • 12. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O, Hörmann K, Klimek L.
    MMW Fortschr Med; 2006 Feb 02; 148(5):28-32. PubMed ID: 16518935
    [Abstract] [Full Text] [Related]

  • 13. Sublingual immunotherapy.
    Esch RE.
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun 02; 16(3):260-4. PubMed ID: 18475082
    [Abstract] [Full Text] [Related]

  • 14. Certainties and doubts about sublingual and oral immunotherapy in children.
    Larenas-Linnemann D.
    Curr Opin Allergy Clin Immunol; 2009 Dec 02; 9(6):558-67. PubMed ID: 19812482
    [Abstract] [Full Text] [Related]

  • 15. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
    Zhu L, Zhu LP, Chen RX, Tao QL, Lu JH, Cheng L.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec 02; 46(12):986-91. PubMed ID: 22336009
    [Abstract] [Full Text] [Related]

  • 16. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules.
    Passali D, Mösges R, Passali GC, Passali FM, Ayoko G, Bellussi L.
    Acta Otorhinolaryngol Ital; 2010 Jun 02; 30(3):131-7. PubMed ID: 20948588
    [Abstract] [Full Text] [Related]

  • 17. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations.
    Cox L.
    Curr Allergy Asthma Rep; 2007 Nov 02; 7(6):410-20. PubMed ID: 17986370
    [Abstract] [Full Text] [Related]

  • 18. [Specific immunotherapy for allergic rhinitis. Current methods and innovative developments].
    Pfaar O, Klimek L.
    HNO; 2008 Aug 02; 56(8):764-75. PubMed ID: 18668217
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous and sublingual immunotherapy for allergic rhinitis: what is the evidence?
    Wise SK, Schlosser RJ.
    Am J Rhinol Allergy; 2012 Aug 02; 26(1):18-22. PubMed ID: 22391071
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of six years allergen immunotherapy in allergic rhinitis and allergic asthma.
    Farid R, Ghasemi R, Baradaran-Rahimi M, Jabbari F, Ghaffari J, Rafatpanah H.
    Iran J Allergy Asthma Immunol; 2006 Mar 02; 5(1):29-31. PubMed ID: 17242501
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.